SlideShare ist ein Scribd-Unternehmen logo
1 von 9
 The decision to participate in a clinical trial is a very personal one. Your type of
cancer, overall condition and priorities are all important in making that decision
with your doctor and treatment team.
 Here are some of the reasons why people decide to participate in a clinical trial:
 Hope – There are no guarantees in a clinical trial. It is a research study designed to
test new treatments and learn whether they work, but for many people, trials do
offer hope. This is particularly true if you are facing an advanced or difficult-to-
treat cancer, or if you have stopped responding to other treatments.
 Access – Access to the most innovative therapies. All new cancer treatments are
studies in clinical trials and many new agents and approaches are available only
through trials before they are approved by the Food and Drug Administration (FDA).
 Care – People in clinical trials get the highest quality care and monitoring of their
cancers.
 Physicians and treatment facilities dedicated to improving treatment – The doctors
and cancer center that participate in clinical trials make a commitment to
advancing cancer treatment and care.
 Progress – By participating in a clinical trial, you contribute to progress in treating
cancer. This is true even if the trial does not work for you. Cancer research owes a
huge debt to the patients who bring courage, optimism and commitment to being in
trials.
 Clinical studies are done to add to knowledge base and develop
new therapies and treatments
 Interventional: Clinical trials
 Receive specific interventions according to research protocol created
by investigator
 Interventions may be medical products, such as drugs or devices;
procedures; or changes to participants' behavior, such as diet
 Compare a new medical approach to available standard approach
 Compare to placebo that contains no active ingredients, or to no
intervention
 Compare interventions that are already available to each other
 Observational:
 Review health outcomes in groups of participants
 Participants are not assigned to specific interventions
 Example, investigators may observe a group of older adults to learn
more about the effects of different lifestyles on cardiac health.
 Phase I Trials:
 These first studies in people evaluate
 How a new drug should be given
 How often
 What dose is safe
 Phase I trial usually enrolls only a small number of patients.
 Phase II Trials:
 A Phase II trial continues to test the safety of the drug
 Starts to evaluate how well the new drug works
 Phase II oncology studies usually focus on a particular type of cancer
 Phase III Trials:
 Test a new drug, a new combination of drugs, or a new surgical procedure in
comparison to the current standard or placebo
 Typically assigned to standard group or new group at random (like flipping a coin)
 Often enroll large numbers of people and may be conducted at many doctor's
offices, clinics, and cancer centers nationwide
 Phase IV Trials:
 Purpose is to evaluate side effects, risks, and benefits of a drug over a longer
period of time and in a larger number of people than in a Phase III clinical trial
 Eligibility
 Will I fit the criteria to take part in the study?
 Location of the study
 How often do I need to be at the hospital?
 Ongoing testing during the study and after
 Frequency of treatment, tests and follow-up
after the study is over
 Who will pay for the treatment?
 Tests, office visits
 Travel
 Reimbursement
 Principal Investigator
 In charge of carrying out the clinical trial
 Clinical Research Nurse
 Collects information about baseline medical conditions, side effects, medications
for data collections
 Coordinates testing/schedules
 Refers to social work for assistance
 Emotional, Housing, Travel
 Clinical Research Coordinator/Data Manager
 Inputs data
 Coordinates testing/schedules
 Social Work
 Assists with the psychosocial impact of cancer
 Lab Coordinator
 Processes and ships specimens
 https://clinicaltrials.gov/ct2/about-
studies/learn#WhatIs
 http://hospitals.jefferson.edu/departments-
and-services/cancer-clinical-trials/phases-of-
clinical-trials/
 American Cancer Society’s Clinical Trial Matching
Service 800-303-5691
www.cancer.org/clinicaltrials
 Cancer Watch 617-856-5900
www.centerwatch.com
 Cancer Support Community 800-814-8927
www.cancersupportcommunity.org/clinicaltrials
 National Cancer Institute’s Clinical Trial Registry
800-422-6237 www.cancer.gov/clinicaltrials
 National Library of Medicine’s Clinical Trials
Search www.clinicaltrials.gov
 Trials Check www.cancertrialshelp.org/trialcheck
 Cancer Support Community’s (CSC) Resources
and Programs are available free of charge.
888-793-9355 or visit
www.cancersupportcommunity.org
 Cancer Support Helpline 888-793-9355
 Open to Options 888-793-9355 or visit
www.cancersupportcommunity.org

Weitere ähnliche Inhalte

Was ist angesagt?

Site & investigator selection
Site & investigator selectionSite & investigator selection
Site & investigator selection
Mukesh Jaiswal
 
KEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIK
KEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIKKEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIK
KEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIK
Dr. Suchismita Banik
 
Good clinical practice by vijay
Good clinical practice by vijayGood clinical practice by vijay
Good clinical practice by vijay
vijaypv
 

Was ist angesagt? (20)

Good Clinical Practice
Good Clinical PracticeGood Clinical Practice
Good Clinical Practice
 
Site & investigator selection
Site & investigator selectionSite & investigator selection
Site & investigator selection
 
Investigator’s meeting
Investigator’s meetingInvestigator’s meeting
Investigator’s meeting
 
Introduction to clinical research - II
Introduction to clinical research - IIIntroduction to clinical research - II
Introduction to clinical research - II
 
KEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIK
KEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIKKEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIK
KEY STAKEHOLDERS IN CLINICAL RESEARCH SUCHISMITA BANIK
 
Importance of clinical trials
Importance of clinical trialsImportance of clinical trials
Importance of clinical trials
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
Ethics of clinical trials
Ethics of clinical trialsEthics of clinical trials
Ethics of clinical trials
 
ICH GOOD CLINICAL PRACTICE
ICH GOOD CLINICAL PRACTICEICH GOOD CLINICAL PRACTICE
ICH GOOD CLINICAL PRACTICE
 
Spontaneous reporting
Spontaneous reporting Spontaneous reporting
Spontaneous reporting
 
Introduction to clinical trials
Introduction to clinical trialsIntroduction to clinical trials
Introduction to clinical trials
 
Clinical Research Presentation
Clinical Research PresentationClinical Research Presentation
Clinical Research Presentation
 
Historical evolution of clinical trial guidelines in the world
Historical evolution of clinical trial guidelines in the worldHistorical evolution of clinical trial guidelines in the world
Historical evolution of clinical trial guidelines in the world
 
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINESICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
 
Clinical trial process
Clinical trial processClinical trial process
Clinical trial process
 
GCP guidelines
GCP guidelines GCP guidelines
GCP guidelines
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trial
 
Clinical trial monitoring
Clinical trial monitoringClinical trial monitoring
Clinical trial monitoring
 
Good clinical practice by vijay
Good clinical practice by vijayGood clinical practice by vijay
Good clinical practice by vijay
 
A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...
 

Andere mochten auch

Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in India
vaatsalya
 

Andere mochten auch (20)

Liver Directed Therapy - Marlana Orloff, MD
Liver Directed Therapy - Marlana Orloff, MDLiver Directed Therapy - Marlana Orloff, MD
Liver Directed Therapy - Marlana Orloff, MD
 
Immunotherapy for Uveal Melanoma - Udai Kammula, MD, FACS
Immunotherapy for Uveal Melanoma - Udai Kammula, MD, FACSImmunotherapy for Uveal Melanoma - Udai Kammula, MD, FACS
Immunotherapy for Uveal Melanoma - Udai Kammula, MD, FACS
 
Advances in Melanoma Oncology - Mike Atkins, MD
Advances in Melanoma Oncology - Mike Atkins, MDAdvances in Melanoma Oncology - Mike Atkins, MD
Advances in Melanoma Oncology - Mike Atkins, MD
 
Ocular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACS
Ocular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACSOcular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACS
Ocular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACS
 
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MDHuntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
 
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MD
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MDTargeted Therapy for Uveal Melanoma - Richard Carvajal, MD
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MD
 
CURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline KraskaCURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline Kraska
 
Emory Eye Tumor SPORE Update - Robin Noe, MD
Emory Eye Tumor SPORE Update - Robin Noe, MDEmory Eye Tumor SPORE Update - Robin Noe, MD
Emory Eye Tumor SPORE Update - Robin Noe, MD
 
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal MelanomaPrognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
 
Clinical trials 101
Clinical trials 101Clinical trials 101
Clinical trials 101
 
ICH and GCP by Naveen
ICH and GCP by NaveenICH and GCP by Naveen
ICH and GCP by Naveen
 
Redefining ETL Pipelines with Apache Technologies to Accelerate Decision-Maki...
Redefining ETL Pipelines with Apache Technologies to Accelerate Decision-Maki...Redefining ETL Pipelines with Apache Technologies to Accelerate Decision-Maki...
Redefining ETL Pipelines with Apache Technologies to Accelerate Decision-Maki...
 
2014 Northwest Melanoma Symposium Slide Deck
2014 Northwest Melanoma Symposium Slide Deck2014 Northwest Melanoma Symposium Slide Deck
2014 Northwest Melanoma Symposium Slide Deck
 
A CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring PracticesA CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring Practices
 
Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity
 
How Diet Affects Cancer Treatment
How Diet Affects Cancer TreatmentHow Diet Affects Cancer Treatment
How Diet Affects Cancer Treatment
 
Clinical Trials Glossary
Clinical Trials GlossaryClinical Trials Glossary
Clinical Trials Glossary
 
Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in India
 
Monitoring Visits
Monitoring VisitsMonitoring Visits
Monitoring Visits
 
Qc in clinical trials
Qc in clinical trialsQc in clinical trials
Qc in clinical trials
 

Ähnlich wie Clinical Trials 101

Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
biinoida
 
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Bhoj Raj Singh
 

Ähnlich wie Clinical Trials 101 (20)

JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENTJOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
 
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
 
Navigating Patients to Clinical Trials
Navigating Patients to Clinical TrialsNavigating Patients to Clinical Trials
Navigating Patients to Clinical Trials
 
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershman
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. HershmanSHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershman
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershman
 
Importance of clinical trials in drug discovery
Importance of clinical trials in drug discoveryImportance of clinical trials in drug discovery
Importance of clinical trials in drug discovery
 
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
 
Clinical trials
Clinical trialsClinical trials
Clinical trials
 
About Clinical Trials and Its Potential Benefits of Participating
About Clinical Trials and Its Potential Benefits of ParticipatingAbout Clinical Trials and Its Potential Benefits of Participating
About Clinical Trials and Its Potential Benefits of Participating
 
Clinical trial
Clinical trialClinical trial
Clinical trial
 
Clinical Trials - Why We Need Them?
Clinical Trials - Why We Need Them?Clinical Trials - Why We Need Them?
Clinical Trials - Why We Need Them?
 
# 1st lect 1 intro to interventional research
# 1st lect 1  intro to interventional research# 1st lect 1  intro to interventional research
# 1st lect 1 intro to interventional research
 
Testing of drugs on human volunteers
Testing of drugs on human volunteersTesting of drugs on human volunteers
Testing of drugs on human volunteers
 
COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN CLINICAL RESEARCH INTERV...
COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN CLINICAL RESEARCH INTERV...COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN CLINICAL RESEARCH INTERV...
COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN CLINICAL RESEARCH INTERV...
 
Clinical research basic things
Clinical research basic thingsClinical research basic things
Clinical research basic things
 
Understanding clinical research
Understanding clinical researchUnderstanding clinical research
Understanding clinical research
 
Cr importance-1
Cr importance-1Cr importance-1
Cr importance-1
 
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
 
trials.pptx
trials.pptxtrials.pptx
trials.pptx
 
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
 

Mehr von Melanoma Research Foundation

Mehr von Melanoma Research Foundation (20)

Ocumel Ireland - 2019 CURE OM Symposium
Ocumel Ireland - 2019 CURE OM SymposiumOcumel Ireland - 2019 CURE OM Symposium
Ocumel Ireland - 2019 CURE OM Symposium
 
OcuMel UK - 2019 CURE OM Symposium
OcuMel UK - 2019 CURE OM SymposiumOcuMel UK - 2019 CURE OM Symposium
OcuMel UK - 2019 CURE OM Symposium
 
Ocumel Canada - 2019 CURE OM Symposium
Ocumel Canada - 2019 CURE OM SymposiumOcumel Canada - 2019 CURE OM Symposium
Ocumel Canada - 2019 CURE OM Symposium
 
2019 CURE OM Symposium
2019 CURE OM Symposium2019 CURE OM Symposium
2019 CURE OM Symposium
 
About CURE OM - 2019 CURE OM Symposium
About CURE OM - 2019 CURE OM SymposiumAbout CURE OM - 2019 CURE OM Symposium
About CURE OM - 2019 CURE OM Symposium
 
Metastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
Metastatic Uveal Melanoma Treatment - 2019 CURE OM SymposiumMetastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
Metastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
 
Uveal Melanoma Liver Metastases - 2019 CURE OM Symposium
Uveal Melanoma Liver Metastases - 2019 CURE OM SymposiumUveal Melanoma Liver Metastases - 2019 CURE OM Symposium
Uveal Melanoma Liver Metastases - 2019 CURE OM Symposium
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM Symposium
 
Targeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
Targeted Therapy Clinical Trial Update - 2019 CURE OM SymposiumTargeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
Targeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
 
Unique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM SymposiumUnique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM Symposium
 
Auburn Uveal Melanoma Study - 2019 CURE OM Symposium
Auburn Uveal Melanoma Study - 2019 CURE OM SymposiumAuburn Uveal Melanoma Study - 2019 CURE OM Symposium
Auburn Uveal Melanoma Study - 2019 CURE OM Symposium
 
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM SymposiumThe Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
 
Clinical Trials Panel Discussion: 2019 CURE OM Symposium
Clinical Trials Panel Discussion: 2019 CURE OM SymposiumClinical Trials Panel Discussion: 2019 CURE OM Symposium
Clinical Trials Panel Discussion: 2019 CURE OM Symposium
 
Unique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM SymposiumUnique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM Symposium
 
Welcome - 2019 CURE OM Symposium
Welcome - 2019 CURE OM SymposiumWelcome - 2019 CURE OM Symposium
Welcome - 2019 CURE OM Symposium
 
Radiology Basics
Radiology BasicsRadiology Basics
Radiology Basics
 
Balancing Work, Life and Melanoma Treatment
Balancing Work, Life and Melanoma TreatmentBalancing Work, Life and Melanoma Treatment
Balancing Work, Life and Melanoma Treatment
 
A Potential Molecular Target for the Treatment of Uveal Melanoma
A Potential Molecular Target for the Treatment of Uveal MelanomaA Potential Molecular Target for the Treatment of Uveal Melanoma
A Potential Molecular Target for the Treatment of Uveal Melanoma
 
Liver Directed Therapies
Liver Directed TherapiesLiver Directed Therapies
Liver Directed Therapies
 
Understanding Scans 101
Understanding Scans 101Understanding Scans 101
Understanding Scans 101
 

Kürzlich hochgeladen

Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 

Kürzlich hochgeladen (20)

Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 

Clinical Trials 101

  • 1.
  • 2.  The decision to participate in a clinical trial is a very personal one. Your type of cancer, overall condition and priorities are all important in making that decision with your doctor and treatment team.  Here are some of the reasons why people decide to participate in a clinical trial:  Hope – There are no guarantees in a clinical trial. It is a research study designed to test new treatments and learn whether they work, but for many people, trials do offer hope. This is particularly true if you are facing an advanced or difficult-to- treat cancer, or if you have stopped responding to other treatments.  Access – Access to the most innovative therapies. All new cancer treatments are studies in clinical trials and many new agents and approaches are available only through trials before they are approved by the Food and Drug Administration (FDA).  Care – People in clinical trials get the highest quality care and monitoring of their cancers.  Physicians and treatment facilities dedicated to improving treatment – The doctors and cancer center that participate in clinical trials make a commitment to advancing cancer treatment and care.  Progress – By participating in a clinical trial, you contribute to progress in treating cancer. This is true even if the trial does not work for you. Cancer research owes a huge debt to the patients who bring courage, optimism and commitment to being in trials.
  • 3.  Clinical studies are done to add to knowledge base and develop new therapies and treatments  Interventional: Clinical trials  Receive specific interventions according to research protocol created by investigator  Interventions may be medical products, such as drugs or devices; procedures; or changes to participants' behavior, such as diet  Compare a new medical approach to available standard approach  Compare to placebo that contains no active ingredients, or to no intervention  Compare interventions that are already available to each other  Observational:  Review health outcomes in groups of participants  Participants are not assigned to specific interventions  Example, investigators may observe a group of older adults to learn more about the effects of different lifestyles on cardiac health.
  • 4.  Phase I Trials:  These first studies in people evaluate  How a new drug should be given  How often  What dose is safe  Phase I trial usually enrolls only a small number of patients.  Phase II Trials:  A Phase II trial continues to test the safety of the drug  Starts to evaluate how well the new drug works  Phase II oncology studies usually focus on a particular type of cancer  Phase III Trials:  Test a new drug, a new combination of drugs, or a new surgical procedure in comparison to the current standard or placebo  Typically assigned to standard group or new group at random (like flipping a coin)  Often enroll large numbers of people and may be conducted at many doctor's offices, clinics, and cancer centers nationwide  Phase IV Trials:  Purpose is to evaluate side effects, risks, and benefits of a drug over a longer period of time and in a larger number of people than in a Phase III clinical trial
  • 5.  Eligibility  Will I fit the criteria to take part in the study?  Location of the study  How often do I need to be at the hospital?  Ongoing testing during the study and after  Frequency of treatment, tests and follow-up after the study is over  Who will pay for the treatment?  Tests, office visits  Travel  Reimbursement
  • 6.  Principal Investigator  In charge of carrying out the clinical trial  Clinical Research Nurse  Collects information about baseline medical conditions, side effects, medications for data collections  Coordinates testing/schedules  Refers to social work for assistance  Emotional, Housing, Travel  Clinical Research Coordinator/Data Manager  Inputs data  Coordinates testing/schedules  Social Work  Assists with the psychosocial impact of cancer  Lab Coordinator  Processes and ships specimens
  • 8.  American Cancer Society’s Clinical Trial Matching Service 800-303-5691 www.cancer.org/clinicaltrials  Cancer Watch 617-856-5900 www.centerwatch.com  Cancer Support Community 800-814-8927 www.cancersupportcommunity.org/clinicaltrials  National Cancer Institute’s Clinical Trial Registry 800-422-6237 www.cancer.gov/clinicaltrials  National Library of Medicine’s Clinical Trials Search www.clinicaltrials.gov  Trials Check www.cancertrialshelp.org/trialcheck
  • 9.  Cancer Support Community’s (CSC) Resources and Programs are available free of charge. 888-793-9355 or visit www.cancersupportcommunity.org  Cancer Support Helpline 888-793-9355  Open to Options 888-793-9355 or visit www.cancersupportcommunity.org